Skip to main content
Clinical Trials/ITMCTR2200006030
ITMCTR2200006030Not yet recruitingPhase 1

An exploratory randomized controlled study of qianma Zhisou granule in the treatment of cough after infection

The First Affiliated Hospital of Henan University of traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 60 (—)
Sex
All

Inclusion Criteria

  • ? It is consistent with the diagnosis of cough after infection by traditional Chinese and Western medicine;
  • ? Course of disease = 3 weeks and < 8 weeks;
  • ? Those aged = 18 and = 60;
  • ? The subjects were informed and voluntarily signed the informed consent form.

Exclusion Criteria

  • ? Allergic to known traditional Chinese medicine ingredients;
  • ? Patients with unstable angina pectoris, acute myocardial infarction, resting pulmonary artery pressure > 45mmhg, cardiac function grade 2 and above;
  • ? Combined with some chronic diseases, such as chronic obstructive pulmonary disease, bronchial asthma, cough variant asthma, reflux esophagitis, chronic pharyngitis, etcIrritable cough;
  • ? Severe liver and kidney disease (severe liver disease refers to liver cirrhosis, portal hypertension and variceal bleeding. Severe kidney disease includes dialysis and kidney transplantation)
  • ? Pregnant or preparing pregnant women, lactating women;
  • ? Those who have participated in clinical trials of other drugs in recent 1 month;
  • ? Patients with purulent sputum or suppurative tonsillitis;
  • ? Patients with dementia and various mental diseases;
  • ? Those who are participating in clinical trials of other interventions.

Investigators

Sponsor
The First Affiliated Hospital of Henan University of traditional Chinese Medicine

Similar Trials